Literature DB >> 12654239

Treatment of established osteoporosis: a systematic review and cost-utility analysis.

J A Kanis1, J E Brazier, M Stevenson, N W Calvert, M Lloyd Jones.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12654239     DOI： 10.3310/hta6290

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN： 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  59 in total

1.  Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.

Authors:  F Borgström; O Ström; M Kleman; E McCloskey; H Johansson; A Odén; J A Kanis
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

2.  Action Plan for the prevention of osteoporotic fractures in the European Community.

Authors:  Juliet Compston
Journal:  Osteoporos Int       Date:  2004-02-18       Impact factor: 4.507

Review 3.  Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature.

Authors:  Rachael L Fleurence; Cynthia P Iglesias; David J Torgerson
Journal:  Osteoporos Int       Date:  2005-06-25       Impact factor: 4.507

4.  Requirements for DXA for the management of osteoporosis in Europe.

Authors:  J A Kanis; O Johnell
Journal:  Osteoporos Int       Date:  2004-12-24       Impact factor: 4.507

5.  Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.

Authors:  Fredrik Borgström; Olof Johnell; John A Kanis; Anders Oden; David Sykes; Bengt Jönsson
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  Can fall risk be incorporated into fracture risk assessment algorithms: a pilot study of responsiveness to clodronate.

Authors:  K Kayan; H Johansson; A Oden; S Vasireddy; K Pande; J Orgee; J A Kanis; E V McCloskey
Journal:  Osteoporos Int       Date:  2009-05-13       Impact factor: 4.507

7.  The risk and burden of vertebral fractures in Sweden.

Authors:  J A Kanis; O Johnell; A Oden; F Borgstrom; N Zethraeus; C De Laet; B Jonsson
Journal:  Osteoporos Int       Date:  2003-10-31       Impact factor: 4.507

8.  Projection of osteoporosis-related fractures and costs in China: 2010-2050.

Authors:  L Si; T M Winzenberg; Q Jiang; M Chen; A J Palmer
Journal:  Osteoporos Int       Date:  2015-03-12       Impact factor: 4.507

9.  Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis.

Authors:  O Ström; B Jönsson; J A Kanis
Journal:  Osteoporos Int       Date:  2012-12-07       Impact factor: 4.507

10.  The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis.

Authors:  F Borgström; O Ström; J Coelho; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2009-06-10       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.